查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594538

核医放射性同位素市场：按产品类型、应用和最终用户划分 - 全球预测 2025-2030

Nuclear Medicine Radioisotopes Market by Product Type (Diagnostics, Therapeutic), Application (Gastroenterology, Neurology, Oncology), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

核医放射性同位素市场2023年估值为104.6亿美元，预计2024年将达119.4亿美元，复合年增长率为14.50%，到2030年将达270亿美元。

核医放射性同位素是用于医疗领域诊断和治疗应用的放射性物质，是 PET 和 SPECT 扫描等成像技术的重要工具。这种需求源于生物过程的详细和非侵入性视觉化以及治疗癌症、心血管疾病和神经系统疾病等疾病的潜力。最终用途主要包括医院、诊断中心和研究机构。市场成长主要受到慢性病盛行率不断上升、技术进步以及早期诊断意识不断增强的影响。然而，该市场受到诸如手术成本高、监管挑战以及需要严格遵守涉及放射性材料的安全通讯协定等因素的限制。钼 99（放射性同位素生产的关键成分）等材料的供应链由于其复杂性和有限性也可能成为瓶颈。开发更有效率、更具成本效益的同位素并扩大其在肿瘤学以外的领域的应用，特别是神经病学和心臟病学，存在机会。研究机构和商业公司之间的合作伙伴关係可以透过缩小技术开发和临床应用之间的差距来增强创新。为了利用这些机会，相关人员必须投资于新型同位素生产方法的高级研究，例如整合诊断和治疗能力的标靶α疗法和治疗诊断学。改良的输送系统也可能出现创新，以提高放射性同位素应用的精确度、减少副作用并提高治疗效果。由于市场仍然高度竞争和细分，公司有空间透过创新解决方案和策略联盟来应对这些关键挑战并影响市场动态。市场本质上是进步的，但需要适应性策略来跟上技术进步和监管变化。

主要市场统计
基准年[2023] 104.6亿美元
预测年份 [2024] 119.4亿美元
预测年份 [2030] 270亿美元
复合年增长率（%） 14.50%

市场动态：揭示快速发展的核医学放射性同位素市场的关键市场洞察

核医放射性同位素市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对 SPECT、PET 扫描和核子医学的需求不断增长
    • 放射性药物市场显着成长
    • 癌症和心臟病的盛行率增加
  • 市场限制因素
    • 高辐射暴露引起的副作用
  • 市场机会
    • 放射线治疗显着成长
    • 治疗诊断学在核子医学中日益普及
  • 市场问题
    • 严格的政府法规

波特五力：驾驭核医放射性同位素市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解核医放射性同位素市场的外部影响

外部宏观环境因素在塑造核医放射性同位素市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解核医放射性同位素市场的竞争状况

核医放射性同位素市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：核医放射性同位素市场供应商的绩效评估

FPNV 定位矩阵是评估核医放射性同位素市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划核医放射性同位素市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对核医学放射性同位素市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对 SPECT、PET 扫描和核子医学的需求不断增长
      • 放射性药物显着成长
      • 癌症和心臟病的发生率增加
    • 抑制因素
      • 高暴露会导致副作用
    • 机会
      • 放射治疗显着增加
      • 治疗诊断学在核子医学中日益普及
    • 任务
      • 严格的政府法规
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章核医放射性同位素市场：依产品类型

  • 介绍
  • 诊断
    • 氟18
    • 镓67
    • Technetium99
    • 铊201
  • 治疗
    • 碘131
    • 铼186
    • 钐153
    • 钇90

第七章核子医学放射性同位素市场：依应用分类

  • 介绍
  • 胃肠病学
  • 神经病学
  • 肿瘤学
  • 整形外科

第八章核子医学放射性同位素市场：依最终使用者分类

  • 介绍
  • 诊断中心
  • 教育/研究机构
  • 医院
  • 专科诊所

第九章 北美和南美核子医学放射性同位素市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太核医学放射性同位素市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲核子医学放射性同位素市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Bruce Power Inc.
  • Eckert & Ziegler Strahlen-und Medizintechnik AG
  • General Atomics Electromagnetic Systems
  • Grantek Systems
  • International Isotopes Inc.
  • Medical Isotopes, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • Nuclear Research and consultancy Group
  • Ontario Power Generation Inc.
  • Orano Group
  • ROSATOM State Atomic Energy Corporation
  • SHINE Technologies, LLC
  • SOFIE Co.
  • Urenco Stable Isotopes
Product Code: MRR-742BD51821D7

The Nuclear Medicine Radioisotopes Market was valued at USD 10.46 billion in 2023, expected to reach USD 11.94 billion in 2024, and is projected to grow at a CAGR of 14.50%, to USD 27.00 billion by 2030.

Nuclear medicine radioisotopes are radioactive substances used in diagnostic and therapeutic applications within the medical field, serving as vital tools for imaging techniques such as PET and SPECT scans. Their necessity arises from their capacity to provide detailed, non-invasive visualization of biological processes and treatment of conditions like cancer, cardiovascular diseases, and neurological disorders. The end-use scope primarily includes hospitals, diagnostic centers, and research institutions. Market growth is primarily influenced by the increasing prevalence of chronic diseases, technological advancements, and growing awareness regarding early diagnostics. However, the market is limited by factors such as high costs of procedures, regulatory challenges, and the need for strict compliance with safety protocols involving radioactive materials. The supply chain for materials like Molybdenum-99, a key component in radioisotope production, can also be a bottleneck due to its complex and limited nature. Opportunities lie in the development of more efficient and cost-effective isotopes and expanding applications beyond oncology, particularly in neurology and cardiology. Collaborative partnerships between research institutions and commercial enterprises can enhance innovation by bridging gaps between technology development and clinical adoption. To capitalize on these opportunities, it is essential that stakeholders invest in advanced research for novel isotope production methods, such as targeted alpha therapy and theranostics, which integrate diagnostic and therapeutic capabilities. Innovation can also emerge from improving delivery systems to enhance the precision of radioisotope applications, reducing side effects, and increasing therapeutic efficacy. While the market is competitive, it remains fragmented, providing room for entrants who can address these key challenges and influence market dynamics through innovative solutions and strategic alliances. The nature of the market is progressive but requires adaptive strategies to stay aligned with technological advancements and regulatory changes.

KEY MARKET STATISTICS
Base Year [2023] USD 10.46 billion
Estimated Year [2024] USD 11.94 billion
Forecast Year [2030] USD 27.00 billion
CAGR (%) 14.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nuclear Medicine Radioisotopes Market

The Nuclear Medicine Radioisotopes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for SPECT, PET scan and nuclear medicine
    • Remarkable growth of radiopharmaceutical drugs
    • Increasing prevalence of cancer and cardiac disorders
  • Market Restraints
    • Side effects with higher exposure
  • Market Opportunities
    • Substantial growth of radiation therapy
    • Emerging popularity of theranostics in nuclear medicine
  • Market Challenges
    • Stringent government regulations

Porter's Five Forces: A Strategic Tool for Navigating the Nuclear Medicine Radioisotopes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nuclear Medicine Radioisotopes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nuclear Medicine Radioisotopes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nuclear Medicine Radioisotopes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nuclear Medicine Radioisotopes Market

A detailed market share analysis in the Nuclear Medicine Radioisotopes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nuclear Medicine Radioisotopes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nuclear Medicine Radioisotopes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nuclear Medicine Radioisotopes Market

A strategic analysis of the Nuclear Medicine Radioisotopes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Radioisotopes Market, highlighting leading vendors and their innovative profiles. These include Bruce Power Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, General Atomics Electromagnetic Systems, Grantek Systems, International Isotopes Inc., Medical Isotopes, Inc., NorthStar Medical Radioisotopes, LLC, Nuclear Research and consultancy Group, Ontario Power Generation Inc., Orano Group, ROSATOM State Atomic Energy Corporation, SHINE Technologies, LLC, SOFIE Co., and Urenco Stable Isotopes.

Market Segmentation & Coverage

This research report categorizes the Nuclear Medicine Radioisotopes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Diagnostics and Therapeutic. The Diagnostics is further studied across Fluorine-18, Gallium-67, Technetium-99, and Thallium-201. The Therapeutic is further studied across Iodine-131, Rhenium-186, Samarium-153, and Yttrium-90.
  • Based on Application, market is studied across Gastroenterology, Neurology, Oncology, and Orthopedics.
  • Based on End-User, market is studied across Diagnostic Centers, Education & Research Institutes, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for SPECT, PET scan and nuclear medicine
      • 5.1.1.2. Remarkable growth of radiopharmaceutical drugs
      • 5.1.1.3. Increasing prevalence of cancer and cardiac disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects with higher exposure
    • 5.1.3. Opportunities
      • 5.1.3.1. Substantial growth of radiation therapy
      • 5.1.3.2. Emerging popularity of theranostics in nuclear medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nuclear Medicine Radioisotopes Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostics
    • 6.2.1. Fluorine-18
    • 6.2.2. Gallium-67
    • 6.2.3. Technetium-99
    • 6.2.4. Thallium-201
  • 6.3. Therapeutic
    • 6.3.1. Iodine-131
    • 6.3.2. Rhenium-186
    • 6.3.3. Samarium-153
    • 6.3.4. Yttrium-90

7. Nuclear Medicine Radioisotopes Market, by Application

  • 7.1. Introduction
  • 7.2. Gastroenterology
  • 7.3. Neurology
  • 7.4. Oncology
  • 7.5. Orthopedics

8. Nuclear Medicine Radioisotopes Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Education & Research Institutes
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas Nuclear Medicine Radioisotopes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Nuclear Medicine Radioisotopes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Nuclear Medicine Radioisotopes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bruce Power Inc.
  • 2. Eckert & Ziegler Strahlen- und Medizintechnik AG
  • 3. General Atomics Electromagnetic Systems
  • 4. Grantek Systems
  • 5. International Isotopes Inc.
  • 6. Medical Isotopes, Inc.
  • 7. NorthStar Medical Radioisotopes, LLC
  • 8. Nuclear Research and consultancy Group
  • 9. Ontario Power Generation Inc.
  • 10. Orano Group
  • 11. ROSATOM State Atomic Energy Corporation
  • 12. SHINE Technologies, LLC
  • 13. SOFIE Co.
  • 14. Urenco Stable Isotopes

LIST OF FIGURES

  • FIGURE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUCLEAR MEDICINE RADIOISOTOPES MARKET DYNAMICS
  • TABLE 7. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GALLIUM-67, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THALLIUM-201, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY IODINE-131, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY RHENIUM-186, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY EDUCATION & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2023